Trial · NCT03052517
Results by group189
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 189
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Treatment Emergent Adverse Events (AEs) up to Week 52 - Cox Regression Model | QAW039 150mg | 675 | Participants | ||
| Number of Participants With Treatment Emergent Adverse Events (AEs) up to Week 52 - Cox Regression Model | QAW039 450 mg | 654 | Participants | ||
| Number of Participants With Treatment Emergent Adverse Events (AEs) up to Week 52 - Cox Regression Model | Placebo | 237 | Participants | ||
| Number of Participants With Treatment Emergent Adverse Events (AEs) up to Week 156 - Cox Regression Model | QAW039 150mg | 709 | Participants | ||
| Number of Participants With Treatment Emergent Adverse Events (AEs) up to Week 156 - Cox Regression Model | QAW039 450 mg | 681 | Participants | ||
| Number of Participants With Treatment Emergent Adverse Events (AEs) up to Week 156 - Cox Regression Model | Placebo | 243 | Participants | ||
| Number of Participants With Treatment Emergent Serious Adverse Events (SAEs) up to Week 52 - Cox Regression Model | QAW039 150mg | 73 | Participants | ||
| Number of Participants With Treatment Emergent Serious Adverse Events (SAEs) up to Week 52 - Cox Regression Model | QAW039 450 mg | 53 | Participants | ||
| Number of Participants With Treatment Emergent Serious Adverse Events (SAEs) up to Week 52 - Cox Regression Model | Placebo | 29 | Participants | ||
| Number of Participants With Treatment Emergent Serious Adverse Events (SAEs) up to Week 156 - Cox Regression Model | QAW039 150mg | 86 | Participants | ||
| Number of Participants With Treatment Emergent Serious Adverse Events (SAEs) up to Week 156 - Cox Regression Model | QAW039 450 mg | 63 | Participants | ||
| Number of Participants With Treatment Emergent Serious Adverse Events (SAEs) up to Week 156 - Cox Regression Model | Placebo | 33 | Participants | ||
| Number of Participants With Treatment Emergent AEs Leading to Discontinuation From Study Treatment up to Week 52 - Cox Regression Model | QAW039 150mg | 26 | Participants | ||
| Number of Participants With Treatment Emergent AEs Leading to Discontinuation From Study Treatment up to Week 52 - Cox Regression Model | QAW039 450 mg | 33 | Participants | ||
| Number of Participants With Treatment Emergent AEs Leading to Discontinuation From Study Treatment up to Week 52 - Cox Regression Model | Placebo | 9 | Participants | ||
| Number of Participants With Treatment Emergent AEs Leading to Discontinuation From Study Treatment up to Week 156 - Cox Regression Model | QAW039 150mg | 30 | Participants | ||
| Number of Participants With Treatment Emergent AEs Leading to Discontinuation From Study Treatment up to Week 156 - Cox Regression Model | QAW039 450 mg | 37 | Participants | ||
| Number of Participants With Treatment Emergent AEs Leading to Discontinuation From Study Treatment up to Week 156 - Cox Regression Model | Placebo | 9 | Participants | ||
| Number of Patients With at Least One Treatment Emergent AE by Primary System Organ Class up to Week 52 - Logistic Regression Model | QAW039 150mg | Number of patients with at least one AE | 675 | Participants | |
| Number of Patients With at Least One Treatment Emergent AE by Primary System Organ Class up to Week 52 - Logistic Regression Model | QAW039 450 mg | Number of patients with at least one AE | 654 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03052517/results